Vaccines

Methodology

Two stage cluster (30 × 30)

Systematic sampling

BCG

9.2009 × 10−09

2.44173 × 10−06

OPV

OPV1

1.1947 × 10−08

4.87257 × 10−06

OPV2

3.2958 × 10−08

9.70164 × 10−06

OPV3

3.2134 × 10−08

1.32949 × 10−05

OPV4

1.2785 × 10−07

1.56768 × 10−05

OPV5

5.4684 × 10−06

2.29435 × 10−04

OPV6

6.0007 × 10−07

1.06516 × 10−04

OPV7

9.5874 × 10−07

2.73425 × 10−04

DPT

DPT1

3.2958 × 10−08

9.70164 × 10−06

DPT2

6.4818 × 10−08

1.20999 × 10−05

DPT3

9.4344 × 10−08

1.32949 × 10−05

DPT4

6.4134 × 10−07

1.03118 × 10−04

DPT5

9.8328 × 10−07

2.75069 × 10−04

Hepatitis B

HepB1

1.1741 × 10−06

2.7177 × 10−04

HepB2

1.1741 × 10−06

2.71907 × 10−04

Hib

Hib1

1.2841 × 10−06

2.72553 × 10−04

Hib2

1.2814 × 10−06

2.72303 × 10−04

Hib3

1.305 × 10−06

2.72429 × 10−04

Measles

1.6381 × 10−06

2.53068 × 10−04

MMR

1.702 × 10−06

2.75305 × 10−04